Silencing of oncogenic KRAS by mutant-selective small interfering RNA
Bjoern Papke(University of North Carolina at Chapel Hill), Chad V. Pecot(University of North Carolina at Chapel Hill)
Cited by 2
Related Papers
Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer
|Cancer Research|2022|160
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
|Cell Reports|2020|108
Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking
|Nature Communications|2018|104
Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes
|Nature Communications|2019|77
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.
|UNC Libraries|2024|12